Sildenafil as a Candidate Drug for Alzheimer’s Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons is a research paper published in Journal of Alzheimer s Disease (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R21AG083003-01
Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and Longevity
National Institutes of Health
Grant: 1RF1AG082211-01
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
National Institutes of Health
Grant: 5R01AG053798-02
Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease
National Institutes of Health
Grant: 5R01AG076448-03
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
National Institutes of Health
Grant: 1R56AG074001-01
Multimodal single-cell genomic and epigenomic analyses elucidate Alzheimer’s sexual dimorphism in human immune systems aging
National Institutes of Health
Grant: 5U01AG073323-05
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
National Institutes of Health
Grant: 1RF1AG048083-01
Elucidating AD genotype-phenotype relationships using genetics of human IPS cells
National Institutes of Health
Grant: 1R56AG057478-01
Integrated Cell-type Specific Biological Annotation of Genomic Variants in Alzheimer Disease
National Institutes of Health
Grant: 5R01AG082118-02
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
National Institutes of Health
Grant: 5R35AG071476-02
Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative
National Institutes of Health
Grant: 1I01BX005976-01A1
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
National Institutes of Health
Grant: 5U24AG021886-18
National Cell Repository for Alzheimer's Disease (NCRAD)
National Institutes of Health
Grant: 5P30AG072959-02
Cleveland Alzheimers Disease Research Center
National Institutes of Health
Grant: 5R01AG066707-04
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
National Institutes of Health
Grant: 5R01AG084250-03
Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease
National Institutes of Health
Grant: 5U01NS093334-02
Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors
National Institutes of Health
Grant: 5P20GM109025-03
COBRE GRANT
National Institutes of Health
Grant: 1RF1NS133812-01
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia
Fields of Study
Keywords